Opdivo’s EU Colorectal Cancer Setback ‘More Than Offset’ By Potential Gains In Combination

 
• By Ian Schofield
  
Digital illustration of Cancer cell in colour background
BMS has withdrawn its EU Opdivo filing for colorectal cancer

More from New Products

More from Scrip